Cargando…

Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration

Patient: Female, 39-year-old Final Diagnosis: Hemolytic transfusion reaction Symptoms: Hemolysis • severe anemia Medication: — Clinical Procedure: — Specialty: Hematology OBJECTIVE: Rare co-existance of disease or pathology BACKGROUND: Delayed hemolytic transfusion reactions (DHTR) are life-threaten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cannas, Giovanna, Dubreuil, Léa, Fichez, Axel, Gerfaud-Valentin, Mathieu, Debard, Anne-Lise, Hot, Arnaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130975/ https://www.ncbi.nlm.nih.gov/pubmed/33983909 http://dx.doi.org/10.12659/AJCR.931107

Ejemplares similares

Pregnant Woman with Atypical Hemolytic Uremic Syndrome Delivered a Healthy Newborn under Eculizumab Treatment
por: Demir, Erol, et al.
Publicado: (2016)

Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016)

Atypical hemolytic uremic syndrome and eculizumab therapy in children
por: Kim, Seong Heon, et al.
Publicado: (2018)

Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab
por: Ebrahem, Rawaa, et al.
Publicado: (2017)

Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
por: Gomes, Sara Madureira, et al.
Publicado: (2021)

The Importance of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome
por: Santos, Mariana S, et al.
Publicado: (2022)

Delayed hemolytic transfusion reaction with multiple alloantibody (Anti S, N, K) and a monospecific autoanti-JK(b) in intermediate β-thalassemia patient in Tabriz
por: Dolatkhah, Roya, et al.
Publicado: (2013)

Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement
por: Pape, Lars, et al.
Publicado: (2016)

Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?
por: Rodriguez, Eva, et al.
Publicado: (2017)

Utilization Pattern for Eculizumab Among Children With Hemolytic Uremic Syndrome
por: Ranabothu, Saritha, et al.
Publicado: (2021)

Eculizumab in the Treatment of Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome
por: Azad, Farhan, et al.
Publicado: (2023)

Eculizumab in the Treatment of Acetylcysteine-Induced Atypical Hemolytic Uremic Syndrome
por: Jalbert, Arielle, et al.
Publicado: (2023)

Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia
por: Bezirgiannidou, Zoe, et al.
Publicado: (2016)

Resolution of alloimmunization and refractory autoimmune hemolytic anemia in a multi-transfused beta-thalassemia major patient
por: Philip, Joseph, et al.
Publicado: (2014)

A Case of Atypical Hemolytic Uremic Syndrome Successfully Treated with Eculizumab
por: Thajudeen, B., et al.
Publicado: (2013)

Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab
por: Webb, Tennille N., et al.
Publicado: (2015)

Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab
por: Raufi, Alexander G., et al.
Publicado: (2016)

Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome
por: Trimarchi, Hernán, et al.
Publicado: (2020)

Atypical Hemolytic Uremic Syndrome After Liver Transplant Treated With Eculizumab
por: Bhatti, Sundus, et al.
Publicado: (2020)

Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
por: Wijnsma, Kioa L., et al.
Publicado: (2018)

189 Eculizumab Therapy for Gemcitabine-Induced Atypical Hemolytic Uremic Syndrome
Publicado: (2021)

Myocarditis in Adult-Onset Still Disease
por: Gerfaud-Valentin, Mathieu, et al.
Publicado: (2014)

Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count
por: Dorresteijn, Eiske M., et al.
Publicado: (2012)

Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome
por: Vilalta, Ramon, et al.
Publicado: (2012)

Eculizumab Therapy Leads to Rapid Resolution of Thrombocytopenia in Atypical Hemolytic Uremic Syndrome
por: Tsai, Han-Mou, et al.
Publicado: (2014)

Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab
por: Andries, Gabriela, et al.
Publicado: (2017)

Correction to: Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
por: Wijnsma, Kioa L., et al.
Publicado: (2019)

COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy
por: Gill, Jasmeet, et al.
Publicado: (2021)

The Use of Eculizumab for the Treatment of Atypical Hemolytic Uremic Syndrome in an Academic Hematology Center
por: Thomas, Katharine, et al.
Publicado: (2023)

Eculizumab use in patients with pneumococcal-associated hemolytic uremic syndrome and kidney outcomes
por: Konopásek, Patrik, et al.
Publicado: (2023)

Adult-Onset Still Disease: Manifestations, Treatment, Outcome, and Prognostic Factors in 57 Patients
por: Gerfaud-Valentin, Mathieu, et al.
Publicado: (2014)

Placental disposition of eculizumab, C5 and C5‐eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria
por: Eliesen, Gaby A.M., et al.
Publicado: (2020)

Post-streptococcal glomerulonephritis associated with atypical hemolytic uremic syndrome: to treat or not to treat with eculizumab?
por: Kakajiwala, Aadil, et al.
Publicado: (2016)

A Case Report and Literature Review of Eculizumab Withdrawal in Atypical Hemolytic-Uremic Syndrome
por: Quiroga, Borja, et al.
Publicado: (2016)

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome
por: Siedlecki, Andrew M., et al.
Publicado: (2018)

Activated Prothrombin Complex Concentrate-Induced Atypical Hemolytic Uremic Syndrome Treated with Eculizumab
por: Tsai, Hsin Hsiang Clarence, et al.
Publicado: (2021)

Efficacy of Eculizumab in Coexisting Complement C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome
por: Busutti, Marco, et al.
Publicado: (2020)

Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome
por: Glover, Emily K., et al.
Publicado: (2023)

Eculizumab Versus Ravulizumab for the Treatment of Atypical Hemolytic Uremic Syndrome: A Systematic Review
por: Shahid, Kamran, et al.
Publicado: (2023)

Pulmonary Functions in Transfusion-Dependent Thalassemia
por: Chandra, Jagdish, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j8tdq57hna0tk1sgivrgc4ttf1